On March 22, 2024, OliX Pharmaceuticals, Inc closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11,560 KRW | -8.40% | -13.92% | -20.71% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
38,000 KRW | -0.39% | +5.26% | 2.44B | ||
12,340 KRW | -1.99% | +4.40% | 3.05B | ||
11,560 KRW | -8.40% | -13.92% | 138M | ||
7,100 KRW | -1.66% | +1.57% | 2.65B | ||
1st Jan change | Capi. | |
---|---|---|
-20.71% | 138M | |
+15.19% | 121B | |
+19.91% | 114B | |
+8.24% | 23.61B | |
-19.80% | 20.43B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+2.13% | 13.54B | |
+66.67% | 15.19B |
- Stock Market
- Equities
- A226950 Stock
- News OliX Pharmaceuticals, Inc
- OliX Pharmaceuticals, Inc announced that it has received KRW 14.7 billion in funding from a group of investors